cd45ro apc Search Results


apc vio770 anti cd45ro  (Miltenyi Biotec)
95
Miltenyi Biotec apc vio770 anti cd45ro
Apc Vio770 Anti Cd45ro, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/apc vio770 anti cd45ro/product/Miltenyi Biotec
Average 95 stars, based on 1 article reviews
apc vio770 anti cd45ro - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier
anti human cd45ro apc  (Cytek Biosciences)
92
Cytek Biosciences anti human cd45ro apc
Anti Human Cd45ro Apc, supplied by Cytek Biosciences, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti human cd45ro apc/product/Cytek Biosciences
Average 92 stars, based on 1 article reviews
anti human cd45ro apc - by Bioz Stars, 2026-03
92/100 stars
  Buy from Supplier
cd45ro apc vio770  (Miltenyi Biotec)
94
Miltenyi Biotec cd45ro apc vio770
Cd45ro Apc Vio770, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd45ro apc vio770/product/Miltenyi Biotec
Average 94 stars, based on 1 article reviews
cd45ro apc vio770 - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier
apc conjugated cd45ro mab  (Miltenyi Biotec)
95
Miltenyi Biotec apc conjugated cd45ro mab
Apc Conjugated Cd45ro Mab, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/apc conjugated cd45ro mab/product/Miltenyi Biotec
Average 95 stars, based on 1 article reviews
apc conjugated cd45ro mab - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier
cd45ro apc  (Miltenyi Biotec)
94
Miltenyi Biotec cd45ro apc
Comparison of immunophenotypes between CAR.MUC1-41BB ζ and CAR.MUC1-CD28 ζ . The phenotypic analyses of CAR T cells were performed on days 4, 11, and 14 after transduction. (a) Representative flow cytometry plot demonstrating the cell subset analyzed with fluorochrome-conjugated anti-CD3 and anti-CD56 on day 4 after T cell transduction. (b) Bar graph represents the percentage of CD3 + T cells (mean ± S.E.M from 8 donors). (c) Representative flow cytometry plot at 4 and 11 after transduction. (d) Mean percentage of CD8 + : CD4 + ratio on day 4 and day 11 after transduction is shown. Data shown are mean ± S.E.M from 6 donors. (e) Representative flow cytometry analysis of memory phenotype analyzed on days 4, 11, and 14 after transduction; CAR T cells were expanded in culture media containing IL-2 50 U/ml and stained with <t>anti-CD45RO</t> and anti-CD62L antibody (TEM: CD45RO + CD62L − , TCM: CD45RO + CD62L + , TN: CD45RO − CD62L + , and TE: CD45RO − CD62L − ). (f) The mean percentage of naïve (TN), central memory (TCM), effector memory (TEM), and terminal effector (TE) T cells. Data represents as mean ± S.E.M ( n = 6).
Cd45ro Apc, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd45ro apc/product/Miltenyi Biotec
Average 94 stars, based on 1 article reviews
cd45ro apc - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier
mast cell tryptase antibody, anti-human, apc, readye_lease  (Miltenyi Biotec)
94
Miltenyi Biotec mast cell tryptase antibody, anti-human, apc, readye_lease
Comparison of immunophenotypes between CAR.MUC1-41BB ζ and CAR.MUC1-CD28 ζ . The phenotypic analyses of CAR T cells were performed on days 4, 11, and 14 after transduction. (a) Representative flow cytometry plot demonstrating the cell subset analyzed with fluorochrome-conjugated anti-CD3 and anti-CD56 on day 4 after T cell transduction. (b) Bar graph represents the percentage of CD3 + T cells (mean ± S.E.M from 8 donors). (c) Representative flow cytometry plot at 4 and 11 after transduction. (d) Mean percentage of CD8 + : CD4 + ratio on day 4 and day 11 after transduction is shown. Data shown are mean ± S.E.M from 6 donors. (e) Representative flow cytometry analysis of memory phenotype analyzed on days 4, 11, and 14 after transduction; CAR T cells were expanded in culture media containing IL-2 50 U/ml and stained with <t>anti-CD45RO</t> and anti-CD62L antibody (TEM: CD45RO + CD62L − , TCM: CD45RO + CD62L + , TN: CD45RO − CD62L + , and TE: CD45RO − CD62L − ). (f) The mean percentage of naïve (TN), central memory (TCM), effector memory (TEM), and terminal effector (TE) T cells. Data represents as mean ± S.E.M ( n = 6).
Mast Cell Tryptase Antibody, Anti Human, Apc, Readye Lease, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mast cell tryptase antibody, anti-human, apc, readye_lease/product/Miltenyi Biotec
Average 94 stars, based on 1 article reviews
mast cell tryptase antibody, anti-human, apc, readye_lease - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier
cd38 antibody, anti-human, pe, readye_lease  (Miltenyi Biotec)
94
Miltenyi Biotec cd38 antibody, anti-human, pe, readye_lease
Comparison of immunophenotypes between CAR.MUC1-41BB ζ and CAR.MUC1-CD28 ζ . The phenotypic analyses of CAR T cells were performed on days 4, 11, and 14 after transduction. (a) Representative flow cytometry plot demonstrating the cell subset analyzed with fluorochrome-conjugated anti-CD3 and anti-CD56 on day 4 after T cell transduction. (b) Bar graph represents the percentage of CD3 + T cells (mean ± S.E.M from 8 donors). (c) Representative flow cytometry plot at 4 and 11 after transduction. (d) Mean percentage of CD8 + : CD4 + ratio on day 4 and day 11 after transduction is shown. Data shown are mean ± S.E.M from 6 donors. (e) Representative flow cytometry analysis of memory phenotype analyzed on days 4, 11, and 14 after transduction; CAR T cells were expanded in culture media containing IL-2 50 U/ml and stained with <t>anti-CD45RO</t> and anti-CD62L antibody (TEM: CD45RO + CD62L − , TCM: CD45RO + CD62L + , TN: CD45RO − CD62L + , and TE: CD45RO − CD62L − ). (f) The mean percentage of naïve (TN), central memory (TCM), effector memory (TEM), and terminal effector (TE) T cells. Data represents as mean ± S.E.M ( n = 6).
Cd38 Antibody, Anti Human, Pe, Readye Lease, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd38 antibody, anti-human, pe, readye_lease/product/Miltenyi Biotec
Average 94 stars, based on 1 article reviews
cd38 antibody, anti-human, pe, readye_lease - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier
vimentin antibody, anti-human, fitc, reafinity  (Miltenyi Biotec)
94
Miltenyi Biotec vimentin antibody, anti-human, fitc, reafinity
Comparison of immunophenotypes between CAR.MUC1-41BB ζ and CAR.MUC1-CD28 ζ . The phenotypic analyses of CAR T cells were performed on days 4, 11, and 14 after transduction. (a) Representative flow cytometry plot demonstrating the cell subset analyzed with fluorochrome-conjugated anti-CD3 and anti-CD56 on day 4 after T cell transduction. (b) Bar graph represents the percentage of CD3 + T cells (mean ± S.E.M from 8 donors). (c) Representative flow cytometry plot at 4 and 11 after transduction. (d) Mean percentage of CD8 + : CD4 + ratio on day 4 and day 11 after transduction is shown. Data shown are mean ± S.E.M from 6 donors. (e) Representative flow cytometry analysis of memory phenotype analyzed on days 4, 11, and 14 after transduction; CAR T cells were expanded in culture media containing IL-2 50 U/ml and stained with <t>anti-CD45RO</t> and anti-CD62L antibody (TEM: CD45RO + CD62L − , TCM: CD45RO + CD62L + , TN: CD45RO − CD62L + , and TE: CD45RO − CD62L − ). (f) The mean percentage of naïve (TN), central memory (TCM), effector memory (TEM), and terminal effector (TE) T cells. Data represents as mean ± S.E.M ( n = 6).
Vimentin Antibody, Anti Human, Fitc, Reafinity, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/vimentin antibody, anti-human, fitc, reafinity/product/Miltenyi Biotec
Average 94 stars, based on 1 article reviews
vimentin antibody, anti-human, fitc, reafinity - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier
cd20 cytoplasmic antibody, anti-human, fitc, reafinity  (Miltenyi Biotec)
94
Miltenyi Biotec cd20 cytoplasmic antibody, anti-human, fitc, reafinity
Comparison of immunophenotypes between CAR.MUC1-41BB ζ and CAR.MUC1-CD28 ζ . The phenotypic analyses of CAR T cells were performed on days 4, 11, and 14 after transduction. (a) Representative flow cytometry plot demonstrating the cell subset analyzed with fluorochrome-conjugated anti-CD3 and anti-CD56 on day 4 after T cell transduction. (b) Bar graph represents the percentage of CD3 + T cells (mean ± S.E.M from 8 donors). (c) Representative flow cytometry plot at 4 and 11 after transduction. (d) Mean percentage of CD8 + : CD4 + ratio on day 4 and day 11 after transduction is shown. Data shown are mean ± S.E.M from 6 donors. (e) Representative flow cytometry analysis of memory phenotype analyzed on days 4, 11, and 14 after transduction; CAR T cells were expanded in culture media containing IL-2 50 U/ml and stained with <t>anti-CD45RO</t> and anti-CD62L antibody (TEM: CD45RO + CD62L − , TCM: CD45RO + CD62L + , TN: CD45RO − CD62L + , and TE: CD45RO − CD62L − ). (f) The mean percentage of naïve (TN), central memory (TCM), effector memory (TEM), and terminal effector (TE) T cells. Data represents as mean ± S.E.M ( n = 6).
Cd20 Cytoplasmic Antibody, Anti Human, Fitc, Reafinity, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd20 cytoplasmic antibody, anti-human, fitc, reafinity/product/Miltenyi Biotec
Average 94 stars, based on 1 article reviews
cd20 cytoplasmic antibody, anti-human, fitc, reafinity - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

Image Search Results


Comparison of immunophenotypes between CAR.MUC1-41BB ζ and CAR.MUC1-CD28 ζ . The phenotypic analyses of CAR T cells were performed on days 4, 11, and 14 after transduction. (a) Representative flow cytometry plot demonstrating the cell subset analyzed with fluorochrome-conjugated anti-CD3 and anti-CD56 on day 4 after T cell transduction. (b) Bar graph represents the percentage of CD3 + T cells (mean ± S.E.M from 8 donors). (c) Representative flow cytometry plot at 4 and 11 after transduction. (d) Mean percentage of CD8 + : CD4 + ratio on day 4 and day 11 after transduction is shown. Data shown are mean ± S.E.M from 6 donors. (e) Representative flow cytometry analysis of memory phenotype analyzed on days 4, 11, and 14 after transduction; CAR T cells were expanded in culture media containing IL-2 50 U/ml and stained with anti-CD45RO and anti-CD62L antibody (TEM: CD45RO + CD62L − , TCM: CD45RO + CD62L + , TN: CD45RO − CD62L + , and TE: CD45RO − CD62L − ). (f) The mean percentage of naïve (TN), central memory (TCM), effector memory (TEM), and terminal effector (TE) T cells. Data represents as mean ± S.E.M ( n = 6).

Journal: Journal of Immunology Research

Article Title: An In Vitro Comparison of Costimulatory Domains in Chimeric Antigen Receptor T Cell for Breast Cancer Treatment

doi: 10.1155/2022/2449373

Figure Lengend Snippet: Comparison of immunophenotypes between CAR.MUC1-41BB ζ and CAR.MUC1-CD28 ζ . The phenotypic analyses of CAR T cells were performed on days 4, 11, and 14 after transduction. (a) Representative flow cytometry plot demonstrating the cell subset analyzed with fluorochrome-conjugated anti-CD3 and anti-CD56 on day 4 after T cell transduction. (b) Bar graph represents the percentage of CD3 + T cells (mean ± S.E.M from 8 donors). (c) Representative flow cytometry plot at 4 and 11 after transduction. (d) Mean percentage of CD8 + : CD4 + ratio on day 4 and day 11 after transduction is shown. Data shown are mean ± S.E.M from 6 donors. (e) Representative flow cytometry analysis of memory phenotype analyzed on days 4, 11, and 14 after transduction; CAR T cells were expanded in culture media containing IL-2 50 U/ml and stained with anti-CD45RO and anti-CD62L antibody (TEM: CD45RO + CD62L − , TCM: CD45RO + CD62L + , TN: CD45RO − CD62L + , and TE: CD45RO − CD62L − ). (f) The mean percentage of naïve (TN), central memory (TCM), effector memory (TEM), and terminal effector (TE) T cells. Data represents as mean ± S.E.M ( n = 6).

Article Snippet: For cell surface marker analysis, the following antibodies were used: CD56-PE (HCD56/Cat#130-114-551), CD4-FITC (OKT4/130-114-531), CD8-APC (SK1/130-110-679), CD45RO-APC (UCHL1/130-113-556), CD62L-FITC (DREG-56/130-112-077), CD25-APC (BC96/130-113-284) (Miltenyi Biotec, Bergisch Gladbach, Germany), PD1-FITC (EH12.2H7/329904), LAG-3-FITC (11C3C65/369308), TIM-3-APC (F38-2E2/345012), and CD3-PerCP (clone OKT3/317336) (BioLegend, San Diego, CA, USA).

Techniques: Comparison, Transduction, Flow Cytometry, Staining